Copyright Reports & Markets. All rights reserved.

Global Intranasal Drug and Vaccine Delivery Devices Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Intranasal Drug and Vaccine Delivery Devices Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Powder Conveyor
    • 1.3.3 Liquid Delivery Device
    • 1.3.4 Pressurized Metered Dose Inhaler
    • 1.3.5 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Intranasal Drug and Vaccine Delivery Devices Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Respiratory Diseases
    • 1.4.3 Nervous System Disease
    • 1.4.4 Vaccination
    • 1.4.5 Pain Department
    • 1.4.6 Other
  • 1.5 Global Intranasal Drug and Vaccine Delivery Devices Market Size & Forecast
    • 1.5.1 Global Intranasal Drug and Vaccine Delivery Devices Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Intranasal Drug and Vaccine Delivery Devices Sales Quantity (2021-2032)
    • 1.5.3 Global Intranasal Drug and Vaccine Delivery Devices Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Teva Pharmaceuticals
    • 2.1.1 Teva Pharmaceuticals Details
    • 2.1.2 Teva Pharmaceuticals Major Business
    • 2.1.3 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Product and Services
    • 2.1.4 Teva Pharmaceuticals Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Teva Pharmaceuticals Recent Developments/Updates
  • 2.2 GlaxoSmithKline
    • 2.2.1 GlaxoSmithKline Details
    • 2.2.2 GlaxoSmithKline Major Business
    • 2.2.3 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Product and Services
    • 2.2.4 GlaxoSmithKline Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 GlaxoSmithKline Recent Developments/Updates
  • 2.3 Teleflex
    • 2.3.1 Teleflex Details
    • 2.3.2 Teleflex Major Business
    • 2.3.3 Teleflex Intranasal Drug and Vaccine Delivery Devices Product and Services
    • 2.3.4 Teleflex Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Teleflex Recent Developments/Updates
  • 2.4 Intersect
    • 2.4.1 Intersect Details
    • 2.4.2 Intersect Major Business
    • 2.4.3 Intersect Intranasal Drug and Vaccine Delivery Devices Product and Services
    • 2.4.4 Intersect Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Intersect Recent Developments/Updates
  • 2.5 Aptar Pharma
    • 2.5.1 Aptar Pharma Details
    • 2.5.2 Aptar Pharma Major Business
    • 2.5.3 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Product and Services
    • 2.5.4 Aptar Pharma Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Aptar Pharma Recent Developments/Updates
  • 2.6 3M
    • 2.6.1 3M Details
    • 2.6.2 3M Major Business
    • 2.6.3 3M Intranasal Drug and Vaccine Delivery Devices Product and Services
    • 2.6.4 3M Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 3M Recent Developments/Updates
  • 2.7 OptiNose
    • 2.7.1 OptiNose Details
    • 2.7.2 OptiNose Major Business
    • 2.7.3 OptiNose Intranasal Drug and Vaccine Delivery Devices Product and Services
    • 2.7.4 OptiNose Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 OptiNose Recent Developments/Updates
  • 2.8 UCB
    • 2.8.1 UCB Details
    • 2.8.2 UCB Major Business
    • 2.8.3 UCB Intranasal Drug and Vaccine Delivery Devices Product and Services
    • 2.8.4 UCB Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 UCB Recent Developments/Updates
  • 2.9 Bespak
    • 2.9.1 Bespak Details
    • 2.9.2 Bespak Major Business
    • 2.9.3 Bespak Intranasal Drug and Vaccine Delivery Devices Product and Services
    • 2.9.4 Bespak Intranasal Drug and Vaccine Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Bespak Recent Developments/Updates

3 Competitive Environment: Intranasal Drug and Vaccine Delivery Devices by Manufacturer

  • 3.1 Global Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Intranasal Drug and Vaccine Delivery Devices Revenue by Manufacturer (2021-2026)
  • 3.3 Global Intranasal Drug and Vaccine Delivery Devices Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Intranasal Drug and Vaccine Delivery Devices by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Intranasal Drug and Vaccine Delivery Devices Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Intranasal Drug and Vaccine Delivery Devices Manufacturer Market Share in 2025
  • 3.5 Intranasal Drug and Vaccine Delivery Devices Market: Overall Company Footprint Analysis
    • 3.5.1 Intranasal Drug and Vaccine Delivery Devices Market: Region Footprint
    • 3.5.2 Intranasal Drug and Vaccine Delivery Devices Market: Company Product Type Footprint
    • 3.5.3 Intranasal Drug and Vaccine Delivery Devices Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Intranasal Drug and Vaccine Delivery Devices Market Size by Region
    • 4.1.1 Global Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Intranasal Drug and Vaccine Delivery Devices Consumption Value by Region (2021-2032)
    • 4.1.3 Global Intranasal Drug and Vaccine Delivery Devices Average Price by Region (2021-2032)
  • 4.2 North America Intranasal Drug and Vaccine Delivery Devices Consumption Value (2021-2032)
  • 4.3 Europe Intranasal Drug and Vaccine Delivery Devices Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Intranasal Drug and Vaccine Delivery Devices Consumption Value (2021-2032)
  • 4.5 South America Intranasal Drug and Vaccine Delivery Devices Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Type (2021-2032)
  • 5.2 Global Intranasal Drug and Vaccine Delivery Devices Consumption Value by Type (2021-2032)
  • 5.3 Global Intranasal Drug and Vaccine Delivery Devices Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Application (2021-2032)
  • 6.2 Global Intranasal Drug and Vaccine Delivery Devices Consumption Value by Application (2021-2032)
  • 6.3 Global Intranasal Drug and Vaccine Delivery Devices Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Type (2021-2032)
  • 7.2 North America Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Application (2021-2032)
  • 7.3 North America Intranasal Drug and Vaccine Delivery Devices Market Size by Country
    • 7.3.1 North America Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Intranasal Drug and Vaccine Delivery Devices Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Type (2021-2032)
  • 8.2 Europe Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Application (2021-2032)
  • 8.3 Europe Intranasal Drug and Vaccine Delivery Devices Market Size by Country
    • 8.3.1 Europe Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Intranasal Drug and Vaccine Delivery Devices Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Intranasal Drug and Vaccine Delivery Devices Market Size by Region
    • 9.3.1 Asia-Pacific Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Intranasal Drug and Vaccine Delivery Devices Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Type (2021-2032)
  • 10.2 South America Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Application (2021-2032)
  • 10.3 South America Intranasal Drug and Vaccine Delivery Devices Market Size by Country
    • 10.3.1 South America Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Intranasal Drug and Vaccine Delivery Devices Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Market Size by Country
    • 11.3.1 Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Intranasal Drug and Vaccine Delivery Devices Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Intranasal Drug and Vaccine Delivery Devices Market Drivers
  • 12.2 Intranasal Drug and Vaccine Delivery Devices Market Restraints
  • 12.3 Intranasal Drug and Vaccine Delivery Devices Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Intranasal Drug and Vaccine Delivery Devices and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Intranasal Drug and Vaccine Delivery Devices
  • 13.3 Intranasal Drug and Vaccine Delivery Devices Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Intranasal Drug and Vaccine Delivery Devices Typical Distributors
  • 14.3 Intranasal Drug and Vaccine Delivery Devices Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Intranasal Drug and Vaccine Delivery Devices market size was valued at US$ 240 million in 2025 and is forecast to a readjusted size of US$ 334 million by 2032 with a CAGR of 4.9% during review period.
    Delivery devices for intranasal drugs and vaccines
    According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
    This report is a detailed and comprehensive analysis for global Intranasal Drug and Vaccine Delivery Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Intranasal Drug and Vaccine Delivery Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Intranasal Drug and Vaccine Delivery Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Intranasal Drug and Vaccine Delivery Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Intranasal Drug and Vaccine Delivery Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Intranasal Drug and Vaccine Delivery Devices
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Intranasal Drug and Vaccine Delivery Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Teva Pharmaceuticals, GlaxoSmithKline, Teleflex, Intersect, Aptar Pharma, 3M, OptiNose, UCB, Bespak, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Intranasal Drug and Vaccine Delivery Devices market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Powder Conveyor
    Liquid Delivery Device
    Pressurized Metered Dose Inhaler
    Other
    Market segment by Application
    Respiratory Diseases
    Nervous System Disease
    Vaccination
    Pain Department
    Other
    Major players covered
    Teva Pharmaceuticals
    GlaxoSmithKline
    Teleflex
    Intersect
    Aptar Pharma
    3M
    OptiNose
    UCB
    Bespak
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Intranasal Drug and Vaccine Delivery Devices product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Intranasal Drug and Vaccine Delivery Devices, with price, sales quantity, revenue, and global market share of Intranasal Drug and Vaccine Delivery Devices from 2021 to 2026.
    Chapter 3, the Intranasal Drug and Vaccine Delivery Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Intranasal Drug and Vaccine Delivery Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Intranasal Drug and Vaccine Delivery Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Intranasal Drug and Vaccine Delivery Devices.
    Chapter 14 and 15, to describe Intranasal Drug and Vaccine Delivery Devices sales channel, distributors, customers, research findings and conclusion.

    Buy now